HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parveen Abidi Selected Research

Hypertriglyceridemia

10/2007Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Parveen Abidi Research Topics

Disease

2Neoplasms (Cancer)
01/2016 - 11/2013
2Hepatocellular Carcinoma (Hepatoma)
11/2005 - 12/2004
1cyclic Thrombocytopenia
10/2023
1Rare Diseases (Rare Disease)
10/2023
1Primary Myelofibrosis (Myelosclerosis)
11/2013
1Hypertriglyceridemia
10/2007
1Vitamin E Deficiency
04/2004
1Body Weight (Weight, Body)
01/2003
1Lung Injury
01/2003

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2016 - 04/2004
1Cytidine Triphosphate (CTP)IBA
10/2023
1AnthracyclinesIBA
01/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
11/2013
1Oncostatin MIBA
10/2007
1oxidized low density lipoproteinIBA
11/2005
1Sterol Regulatory Element Binding ProteinsIBA
12/2004
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2004
1Transcription Factors (Transcription Factor)IBA
04/2004
1AsbestosIBA
01/2003
1Serpentine Asbestos (Chrysotile)IBA
01/2003